IA
Imran Alibhai
View Imran's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
N/A
2018 - Present · 7 years
N/A
2014 - 2018 · 4 years
Texas BioAlliance
N/A
2013 - 2014 · 1 years
Company Details
2-10 Employees
Tvardi is a privately held, clinical-stage, biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. STAT3 is a central mediator across critical fibrotic signaling pathways that drive uncontrolled deposition, proliferation, survival and immune suppression. STAT3 is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. The company is conducting Phase 2 clinical trials in fibrosis-driven diseases with high unmet need: idiopathic pulmonary fibrosis (NCT05671835) and hepatocellular carcinoma (NCT05440708).
Year Founded
2017
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
2450 Holcombe Blvd, Suite X Houston, TX 77021, US
Keywords
STAT3Small MoleculesCancerInflammatioFibrosis
Discover More About Cleveland Clinic

Find verified contacts of Imran Alibhai in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.